There have been reports that claim that New Jersey is no longer the pharmaceutical powerhouse it used to be, including a recent Asbury Park Press story by Michael L. Diamond (“What NJ needs to learn from other states,” Oct. 18).
We disagree. To paraphrase Mark Twain, reports of New Jersey’s demise are greatly exaggerated.
